BDNF and gastric cancer: Responders with gastric cancer (GC) had larger increases in brain-derived neurotrophic factor levels than nonresponders (44.77% [95% CI, 10.76% to 78.79%] vs −26.2% [95% CI, −58.53% to 6.12%]; P = .003).